The term “fragrance” actually represents a chemical cocktail that can be made up of hundreds of ingredients. Fragrances are found in thousands of consumer products, yet there is little regulatory oversight of the safety of those ingredients. The current system for fragrance safety is run entirely by the industry’s own International Fragrance Association (IFRA) and their research arm, the Research Institute for Fragrance Materials (RIFM). And as our new report, Unpacking the Fragrance Industry exposes — allowing the fragrance industry to self-regulate, and establish itself as the sole authority on fragrance safety, simply does not serve the public health interest. For example:
- The vast majority of the scientific studies on fragrance materials are generated by major fragrance manufacturers or the fragrance trade association’s own laboratories. Largely, these studies have never been published or peer-reviewed, and are not publicly available.
- The RIFM Expert Panel, the “independent” review board which helps oversee the Fragrance Safety Program, operates in secret, without the benefit of public oversight.
- There is no evidence that the RIFM panel has reviewed the safety of several of the most controversial fragrance ingredients, such as hormone-disrupting phthalates and musks or carcinogens, including styrene and pyridine in the last 30-40 years.
This current safety policy creates an inherent conflict of interest. RIFM, the body responsible for determining the safety of fragrances, is governed by a Board of Directors made up of the world’s largest fragrance sellers. They have a vested financial interest in making sure that fragrances are deemed safe.
Trading Public Health for Trade Secrets
The report also debunks the industry myth that fragrance ingredients should enjoy trade secret protections. It spotlights how labeling products with the blanket-term ‘fragrance’ is a holdover from the industry’s long held tradition of keeping trade secrets for fragrance formulas. This has resulted in policy-makers exempting fragrance from ingredient listing requirements in existing or proposed regulations. This lack of disclosure creates a state of ignorance on the part of consumers, scientists, health care providers and their patients regarding what chemicals one is actually exposed to from fragranced products.
In recent decades, the innovations in reverse engineering technology now make it possible to replicate a list of ingredients found in a fragrance with incredible precision. Many manufacturers have the technology in-house to analyze their competitor’s products in order to better understand, imitate or improve upon their scents. Since the fragrance ingredient information can be readily obtained by independent means, the information simply no longer meets the definition of “trade secret.”
Chemicals of Concern in Fragrance
There are more than 3,000 chemicals on IFRA’s Transparency List of chemicals used in the industry. Fragrance safety standards are created by the industry’s International Fragrance Association (IFRA) – there are currently 186 banned or restricted substances on the IFRA safety standards list. However, as the report discloses, in addition to failing to set safety criteria for such chemicals as phthalates, musks and various carcinogens, these safety standards are voluntary. Little to no compliance verification is required from fragrance manufacturers to follow IFRA Standards.
The strength of the industry’s safety program is also called into question when you consider that over 100 of the chemicals on IFRA’s Transparency List can be found on authoritative lists of toxic chemicals around the world including California Prop 65, International Agency for Research on Cancer and the EU Substances of Very High Concern.
These chemicals have been prioritized for review by numerous governmental bodies due to their inherent toxicity– yet these same chemicals do not appear to be prioritized by the IFRA/RIFM safety program.
Bottom line: fragrance has received a free pass for far too long.
Federal and state legislation is needed that requires fragrance to meet an unbiased standard of safety. Senators Feinstein (D-CA) and Susan Collins (R-ME) recently introduced the Personal Care Product Safety Act (S.1014) that seeks to more stringently regulate ingredients in cosmetics. Unfortunately the bill continues to exclude fragrance from disclosure and meeting any real bar of safety.